Instylla, Inc., a developer of resorbable embolics for peripheral vascular embolization, announced that the FDA has approved an ...
Siemens Healthineers announced the strategic focus of its ultrasound business is shifting to procedural imaging and image-guide ...
We value keeping the Device Guide up to date.
News and information on minimally invasive vascular disease therapies, covering peripheral vascular disease, aneurysms, stroke, hypertension, dialysis access, and venous issues.
News and information on minimally invasive vascular disease therapies, covering peripheral vascular disease, aneurysms, stroke, hypertension, dialysis access, and venous issues.
News and information on minimally invasive vascular disease therapies, covering peripheral vascular disease, aneurysms, stroke, hypertension, dialysis access, and venous issues.
News and information on minimally invasive vascular disease therapies, covering peripheral vascular disease, aneurysms, stroke, hypertension, dialysis access, and venous issues.
AdvaMed, the Advanced Medical Technical Association, announced it recommended refinements to the Centers for Medicare & Med ...
The United Kingdom’s Medicines and Healthcare Agency (MHRA) announced that the government confirmed it will continue to a ...
News and information on minimally invasive vascular disease therapies, covering peripheral vascular disease, aneurysms, stroke, hypertension, dialysis access, and venous issues.
News and information on minimally invasive vascular disease therapies, covering peripheral vascular disease, aneurysms, stroke, hypertension, dialysis access, and venous issues.
News and information on minimally invasive vascular disease therapies, covering peripheral vascular disease, aneurysms, stroke, hypertension, dialysis access, and venous issues.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results